HCA HealthcareHCA -0.24%93 EBITDA Margin % is 19.89% as of Mar. 2026, which is 0% above its 10-year median of 19.88. GuruFocus rates HCA with a GF Score™ of 93/100 and a GF Value™ of $451.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, HCA Healthcare ranks better than 75.3% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. HCA Healthcare's EBITDA for the
three
months ended in Mar. 2026 was $3,801 Mil. HCA Healthcare's Revenue for the
three
months ended in Mar. 2026 was $19,109 Mil. Therefore, HCA Healthcare's EBITDA margin for the quarter that ended in Mar. 2026 was 19.89%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
HCA Healthcare EBITDA Margin % Related Terms
HCA Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for HCA Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HCA Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCA Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HCA Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where HCA Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCA Healthcare (HCA) has a EBITDA Margin % of 19.89% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on HCA Healthcare and its competitors. This is near median its historical median of 19.88. Over the past decade, HCA Healthcare's EBITDA Margin % has ranged from 18.81 to 24.26. According to the industry distribution chart, HCA Healthcare ranks #165 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 24.7%.
Is HCA Healthcare's EBITDA Margin % too high?
HCA Healthcare's current EBITDA Margin % of 19.89% is near median its 10-year median of 19.88. Over the past 10 years, this metric has ranged from a low of 18.81 to a high of 24.26. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. HCA Healthcare's value of 19.89% is 94.8% above this industry median. Based on the distribution chart, HCA Healthcare ranks #165 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HCA Healthcare has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HCA Healthcare's EBITDA Margin % compare to THC and DVA?
According to the Healthcare Providers & Services industry distribution chart, HCA Healthcare ranks #165 out of 668 companies for EBITDA Margin %. This places HCA Healthcare in the top 25% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. HCA Healthcare's value of 19.89% is 94.8% above this benchmark. Historically, HCA Healthcare's own EBITDA Margin % has ranged from 18.81 to 24.26 over the past decade. While the company's 10-year median is 19.88 vs. the industry median of 10.21, HCA Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCA Healthcare's current EBITDA Margin % of 19.89% is 94.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on HCA Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCA Healthcare's current EBITDA Margin % is 19.89%, which is near median its own 10-year median of 19.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCA Healthcare stock overvalued right now?
Based on GuruFocus' analysis, HCA Healthcare (HCA) is currently considered Modestly Undervalued. The stock's GF Value™ is $451.56, compared to a current price of $386.82 — trading 14.3% below its estimated fair value. The current EBITDA Margin % is 19.89%, which is near median its 10-year median of 19.88 and 94.8% above the Healthcare Providers & Services industry median of 10.21. HCA Healthcare's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For HCA Healthcare (HCA), the current EBITDA Margin % is 19.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HCA Healthcare (HCA) Overvalued in 2026?
Based on GuruFocus' analysis, HCA Healthcare stock appears to be undervalued.
The current stock price of $386.82 is trading 14.3% below its estimated GF Value™ of $451.56.
GuruFocus considers HCA Healthcare to be Modestly Undervalued.
Key valuation signals for HCA:
EBITDA Margin %: 19.89% (near median its 10-year median of 19.88)
GF Value™: $451.56 vs. price of $386.82 (14.3% below fair value)
Industry Position: 94.8% above the Healthcare Providers & Services median (#165 of 668)
No single metric tells the full story. See the HCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
93GF Score
Get the complete analysis for HCA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCA has been successfully added to your 
